Delivery Order SPE2DB24D8001-SPE2DB24FKYSP
Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $12,846.67 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Stelara 90 mg/mL syringes. The contract has no set-aside designation and is awarded under DLA's pharmaceutical supply chain contracts to support medical supply operations for the U.S. Armed Forces. Dakota Drug, Inc. is an experienced prime contractor to DLA, specializing in providing a wide range of...
- This is a $8,546.68 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the supply of Stelara 90 mg/mL syringes, a biologic drug used to treat autoimmune conditions. There is no set-aside designation for this contract. Dakota Drug, Inc. has over 20 years of experience as a prime contractor to the DLA, providing a wide range of pharmaceutical products, medical supplies,...
- This is a $11,114.44 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business, for the supply of STELARA 90 MG/ML syringes. The contract has an ultimate completion date of May 2, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense, with a significant single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Stelara 90 mg/mL syringes, with a completion date of November 2, 2023, and a ceiling value of $8,600.28. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of STELARA 90 MG/ML SYRINGEML. The contract has a ceiling value of $9,827.80 and an ultimate completion date of April 9, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense, and this award is part of the company's broader...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product STELARA 90 MG/ML SYRINGE. The contract has a firm fixed price ceiling value of $9,397.47 and a period of performance extending until February 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of STELARA 90 MG/ML SYRINGEML. The $11,087.94 contract has a completion date of March 21, 2024 and does not utilize a set-aside. Dakota Drug, Inc. has over two decades of experience providing a wide range of pharmaceutical products and medical supplies to support the DLA Troop Support Medical's mission of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $19,196.40, is for the delivery of STELARA 90 MG/ML SYRINGEML medical supplies. The contract is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is under the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $10,586.33, is for the provision of Stelara 90 mg/mL syringes, which are a biologic medication used to treat autoimmune conditions. The contract has an ultimate completion date of June 18, 2024 and was awarded on June 17, 2024. This...
- This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $9,866.34 firm-fixed-price contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance ending on September 22, 2023. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the Department of...